跳转到主要内容
主页 / 资源 / 网络研讨会点播 / 通过案例研究了解欧洲 HTA 和市场准入的优势和机遇

通过案例研究了解欧洲 HTA 和市场准入的优势和机遇

YouTube video

在欧洲的真实世界数据源中,法国医疗保健数据库 SNDS 是最大、也可能是最全面的医疗保健数据资源,覆盖约 6500 万人的生活,超过 99% 的法国人口和约 10% 的欧洲人口。

In this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at Certara as she discusses strengths and opportunities for HTAs and market access in Europe through case studies.

About Our Speaker

Nadia Quignot is Director, Real World Data solutions & Data analytics at Certara. Over the last >12 years, Nadia has worked on the development of methods to inform risk and benefit/risk assessment and has coordinated a range of (real world) data analytics projects, for European bodies and pharma companies. As a safety scientist at Roche Pharma, she was in charge of risk and benefit/risk evaluations for anti-inflammatory and anti-cancer drugs. In the R&D projects she conducted for European bodies, she was particularly involved in hazard characterization of drugs, pesticides and other food-related and environmental contaminants.

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software